HK2 and breast carcinoma: Furthermore, 1,25(OH)2D treatment reduced the protein levels of hexokinase 2, an enzyme that plays a crucial role in the initial stages of glycolysis, in MCF-7 breast cancer cells, but increased hexokinase 2 protein expression in MDA-MB-231 cells.85